Raugi, Dana N. http://orcid.org/0000-0001-6205-845X
Diallo, Khardiata
Diallo, Mouhamadou Baïla
Faye, Dominique
Cisse, Ousseynou
Smith, Robert A.
Sall, Fatima
Sall, El Hadji Ibrahima
Faye, Khadim
Diatta, Jean Philippe
Diaw, Binetou
Sambou, Jacques
Malomar, Jean Jacques
Hawes, Stephen E.
Seydi, Moussa
Gottlieb, Geoffrey S.
,
Funding for this research was provided by:
National Institutes of Health, National Institute of Allergy & Infectious Diseases (2R01-AI060466, R01-AI120765)
Article History
Received: 1 February 2021
Accepted: 1 December 2021
First Online: 18 December 2021
Declarations
:
: The study was conducted according to procedures approved by the US National Institutes of Health, Institutional Review Boards at the University of Washington and the Senegalese National Ethics Committee for Health Research (CNERS). All participants provided written informed consent for study participation.
: Not applicable.
: SEH has received research grants and research support from the US National Institutes of Health, the University of Washington, and the Bill & Melinda Gates Foundation. MS has received grant funds and clinical support from the ANRS, Glaxo-Smith Kline, and Gilead Sciences. GSG has received research grants and research support from the US National Institutes of Health, the University of Washington, the Bill & Melinda Gates Foundation, Gilead Sciences, Alere Technologies, Merck & Co., Janssen Pharmaceutica, Cerus Corporation, ViiV Healthcare, Bristol-Myers Squibb, Roche Molecular Systems, Abbott Molecular Diagnostics, and THERA Technologies/TaiMed Biologics, Inc. All other authors declare no competing interests.